These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 8640925
1. Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin. Gao XM, Perchellet EM, Davis AW, Newell SW, Hua DH, Perchellet JP. Carcinogenesis; 1996 May; 17(5):1141-8. PubMed ID: 8640925 [Abstract] [Full Text] [Related]
2. Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo. Gao XM, Perchellet EM, Davis AW, Newell SW, Chen G, Hua DH, Perchellet JP. Int J Cancer; 1996 May 16; 66(4):496-505. PubMed ID: 8635865 [Abstract] [Full Text] [Related]
3. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin. Perchellet JP, Abney NL, Thomas RM, Guislain YL, Perchellet EM. Cancer Res; 1987 Jan 15; 47(2):477-85. PubMed ID: 3098411 [Abstract] [Full Text] [Related]
4. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice. Ewing MW, Conti CJ, Phillips JL, Slaga TJ, DiGiovanni J. J Natl Cancer Inst; 1989 May 03; 81(9):676-82. PubMed ID: 2496233 [Abstract] [Full Text] [Related]
5. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Wei H, Bowen R, Zhang X, Lebwohl M. Carcinogenesis; 1998 Aug 03; 19(8):1509-14. PubMed ID: 9744550 [Abstract] [Full Text] [Related]
6. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine. Skarin T, Rozell BL, Bergman J, Toftgård R, Möller L. Chem Biol Interact; 1999 Sep 30; 122(2):89-106. PubMed ID: 10528995 [Abstract] [Full Text] [Related]
7. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis. Verma AK, Boutwell RK. Carcinogenesis; 1980 Mar 30; 1(3):271-6. PubMed ID: 22283009 [Abstract] [Full Text] [Related]
8. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation. Ewing MW, Crysup SE, Phillips JL, Slaga TJ, DiGiovanni J. Carcinogenesis; 1988 Mar 30; 9(3):405-10. PubMed ID: 3125993 [Abstract] [Full Text] [Related]
9. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter. Verma AK. Cancer Res; 1988 Apr 01; 48(7):1736-9. PubMed ID: 3127039 [Abstract] [Full Text] [Related]
10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH. APMIS Suppl; 1994 Apr 01; 41():1-38. PubMed ID: 7946481 [Abstract] [Full Text] [Related]
11. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH. Cancer Res; 1994 Feb 01; 54(3):701-8. PubMed ID: 8306331 [Abstract] [Full Text] [Related]
12. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Slaga TJ, Fischer SM, Nelson K, Gleason GL. Proc Natl Acad Sci U S A; 1980 Jun 01; 77(6):3659-63. PubMed ID: 6774342 [Abstract] [Full Text] [Related]
13. Vitamin E is a complete tumor promoter in mouse skin. Mitchel RE, McCann R. Carcinogenesis; 1993 Apr 01; 14(4):659-62. PubMed ID: 8472330 [Abstract] [Full Text] [Related]
14. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice. Chen LC, Tarone R, Huynh M, De Luca LM. Cancer Lett; 1995 Aug 16; 95(1-2):113-8. PubMed ID: 7656218 [Abstract] [Full Text] [Related]
15. Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils. Perchellet JP, Perchellet EM, Belman S. Nutr Cancer; 1990 Aug 16; 14(3-4):183-93. PubMed ID: 2128117 [Abstract] [Full Text] [Related]
16. 12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol. Reiners JJ, Pavone A, Maldve R, Fischer SM. Carcinogenesis; 1993 Mar 16; 14(3):411-5. PubMed ID: 8453717 [Abstract] [Full Text] [Related]
17. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion. Birt DF, Pelling JC, Anderson J, Barnett T. Carcinogenesis; 1994 Oct 16; 15(10):2341-5. PubMed ID: 7955075 [Abstract] [Full Text] [Related]
18. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion. Ordman AB, Cleaveland JS, Boutwell RK. Cancer Lett; 1985 Oct 16; 29(1):79-84. PubMed ID: 3933814 [Abstract] [Full Text] [Related]
19. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment. Reiners JJ, Pavone A, Rupp T, Cantu AR. Carcinogenesis; 1990 Jan 16; 11(1):129-37. PubMed ID: 2104781 [Abstract] [Full Text] [Related]
20. Comparison of the effects of 3-isobutyl-1-methylxanthine and adenosine cyclic 3':5'-monophosphate on the induction of skin tumors by the initiation-promotion protocol and by the complete carcinogenesis process. Perchellet JP, Boutwell RK. Carcinogenesis; 1982 Jan 16; 3(1):53-60. PubMed ID: 6175435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]